Tax-exempt organizations are facing more scrutiny than ever. Federal and state regulators have signaled an intent to more ...

The all-new KTM 990 RC R, a machine that signals the Austrian brand’s re-entry into the large capacity supersport segment. For enthusiasts who are fond of the raw and radical (but track only) KTM RC ...

There is nothing quite like El Clásico. Whenever Real Madrid and Barcelona play each other, there is no bigger match happening anywhere else in the soccer world. Sunday's clash at the Estadio Santiago ...

A Lancashire school could close its sixth form due to "declining pupil numbers", the trust which runs it has said. Endeavour Learning said it was consulting on the proposal for Ormskirk School after ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Need more time to file taxes? Fill out IRS extension Form 4868 mapodile / Getty Images Taxpayers unable to file their federal income tax return by the filing deadline can apply for an extension with ...

Suzanne is a content marketer, writer, and fact-checker. She holds a Bachelor of Science in Finance degree from Bridgewater State University and helps develop content strategies. Investopedia / ...

Dan is a fully-trained journalist, with a Gold Standard Level 3 Diploma from the National Council for the Training of Journalists. He has a passion for motorcycles of all capacities, but feels at home ...

GBH’s role as a trusted provider of journalism couldn’t be more important than at this moment. We empower our community members to think, question, wonder, and grow in ways that only public media can ...

What if your browser didn’t just help you search, but actively worked alongside you, summarizing articles, drafting emails, or even automating repetitive tasks? Enter ChatGPT Atlas, OpenAI’s ambitious ...

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...